Neurologists Anticipate FDA Approval of Ocrevus as 1st Progressive MS Treatment, Survey Finds
News, Ocrevus
Neurologists in the U.S. expect — or, at least, highly anticipate — that Ocrevus (ocrelizumab), being developed by Roche as a treatment for both relapsing and progressive multiple sclerosis (MS), ... Read more